These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37734874)

  • 21. The new era for the treatment of psoriasis and psoriatic arthritis: perspectives and validated strategies.
    Novelli L; Chimenti MS; Chiricozzi A; Perricone R
    Autoimmun Rev; 2014 Jan; 13(1):64-9. PubMed ID: 24021172
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diabetes incidence in psoriatic arthritis, psoriasis and rheumatoid arthritis: a UK population-based cohort study.
    Dubreuil M; Rho YH; Man A; Zhu Y; Zhang Y; Love TJ; Ogdie A; Gelfand JM; Choi HK
    Rheumatology (Oxford); 2014 Feb; 53(2):346-52. PubMed ID: 24185762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment Patterns and Healthcare Resource Utilization Among Newly Diagnosed Psoriasis, Psoriatic Arthritis, Axial Spondyloarthritis, and Hidradenitis Suppurativa Patients with Past Diagnosis of an Inflammatory Condition: A Retrospective Cohort Analysis of Claims Data in the United States.
    Hopson S; Gibbs LR; Syed S; Low R; McClung L; Beaty S
    Adv Ther; 2023 Oct; 40(10):4358-4376. PubMed ID: 37486558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New biologics for psoriasis and psoriatic arthritis.
    Rozenblit M; Lebwohl M
    Dermatol Ther; 2009; 22(1):56-60. PubMed ID: 19222517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of Inflammatory Bowel Disease in Patients With Psoriasis and Psoriatic Arthritis/Ankylosing Spondylitis Initiating Interleukin-17 Inhibitors: A Nationwide Population-Based Study Using the French National Health Data System.
    Penso L; Bergqvist C; Meyer A; Herlemont P; Weill A; Zureik M; Dray-Spira R; Sbidian E
    Arthritis Rheumatol; 2022 Feb; 74(2):244-252. PubMed ID: 34279061
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The burden of autoimmune disease: a comparison of prevalence ratios in patients with psoriatic arthritis and psoriasis.
    Makredes M; Robinson D; Bala M; Kimball AB
    J Am Acad Dermatol; 2009 Sep; 61(3):405-10. PubMed ID: 19700012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
    Sbidian E; Chaimani A; Garcia-Doval I; Doney L; Dressler C; Hua C; Hughes C; Naldi L; Afach S; Le Cleach L
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD011535. PubMed ID: 33871055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypercholesterolemia and risk of incident psoriasis and psoriatic arthritis in US women.
    Wu S; Li WQ; Han J; Sun Q; Qureshi AA
    Arthritis Rheumatol; 2014 Feb; 66(2):304-10. PubMed ID: 24504802
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Time to transition from psoriasis to psoriatic arthritis: A population-based study.
    Karmacharya P; Wright K; Achenbach SJ; Crowson CS; Ogdie A; Bekele D; Duarte-García A; Ernste FC; Tollefson MM; Davis Iii JM
    Semin Arthritis Rheum; 2022 Feb; 52():151949. PubMed ID: 35000786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of psoriatic arthritis and comorbidities on ustekinumab outcomes in psoriasis: a retrospective, observational BADBIR cohort study.
    Tillett W; Ogdie A; Passey A; Gorecki P
    RMD Open; 2023 Jan; 9(1):. PubMed ID: 36650006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence rates of inflammatory bowel disease in patients with psoriasis, psoriatic arthritis and ankylosing spondylitis treated with secukinumab: a retrospective analysis of pooled data from 21 clinical trials.
    Schreiber S; Colombel JF; Feagan BG; Reich K; Deodhar AA; McInnes IB; Porter B; Das Gupta A; Pricop L; Fox T
    Ann Rheum Dis; 2019 Apr; 78(4):473-479. PubMed ID: 30674475
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: a population-based study.
    Wilson FC; Icen M; Crowson CS; McEvoy MT; Gabriel SE; Kremers HM
    Arthritis Rheum; 2009 Feb; 61(2):233-9. PubMed ID: 19177544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolic syndrome, non-alcoholic fatty liver disease and liver stiffness in psoriatic arthritis and psoriasis patients.
    Ortolan A; Lorenzin M; Tadiotto G; Russo FP; Oliviero F; Felicetti M; D'Incà R; Favero M; Piaserico S; Doria A; Ramonda R
    Clin Rheumatol; 2019 Oct; 38(10):2843-2850. PubMed ID: 31254236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psoriatic arthritis for dermatologists.
    Gottlieb A; Merola JF
    J Dermatolog Treat; 2020 Nov; 31(7):662-679. PubMed ID: 31014154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of aspirin, non-steroidal anti-inflammatory drugs, and acetaminophen (paracetamol), and risk of psoriasis and psoriatic arthritis: a cohort study.
    Wu S; Han J; Qureshi AA
    Acta Derm Venereol; 2015 Feb; 95(2):217-23. PubMed ID: 24691893
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of biological drugs in patients with psoriasis and psoriatic arthritis in Italy: Results from the PSONG survey.
    Potenza MC; Peris K; Berardesca E; Bianchi L; Richetta A; Bernardini N; De Simone C; Teoli M; Zangrilli A; D'epiro S; Orsini D; Narcisi A; Chimenti S; Costanzo A
    Dermatol Ther; 2018 Jan; 31(1):. PubMed ID: 29215183
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term safety of secukinumab in patients with moderate-to-severe plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis: integrated pooled clinical trial and post-marketing surveillance data.
    Deodhar A; Mease PJ; McInnes IB; Baraliakos X; Reich K; Blauvelt A; Leonardi C; Porter B; Das Gupta A; Widmer A; Pricop L; Fox T
    Arthritis Res Ther; 2019 May; 21(1):111. PubMed ID: 31046809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disease interception with interleukin-17 inhibition in high-risk psoriasis patients with subclinical joint inflammation-data from the prospective IVEPSA study.
    Kampylafka E; Simon D; d'Oliveira I; Linz C; Lerchen V; Englbrecht M; Rech J; Kleyer A; Sticherling M; Schett G; Hueber AJ
    Arthritis Res Ther; 2019 Jul; 21(1):178. PubMed ID: 31349876
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
    Sbidian E; Chaimani A; Afach S; Doney L; Dressler C; Hua C; Mazaud C; Phan C; Hughes C; Riddle D; Naldi L; Garcia-Doval I; Le Cleach L
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD011535. PubMed ID: 31917873
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin-17A: a unique pathway in immune-mediated diseases: psoriasis, psoriatic arthritis and rheumatoid arthritis.
    Kirkham BW; Kavanaugh A; Reich K
    Immunology; 2014 Feb; 141(2):133-42. PubMed ID: 23819583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.